论文部分内容阅读
目的:观察痰热清注射液治疗小儿重症肺炎的临床疗效。方法:将72例重症肺炎患儿随机分为治疗组和对照组,各36例,两组均给予相同的常规治疗,治疗组在常规治疗的基础上给予痰热清+头孢甲肟,对照组给予利巴韦林+头孢甲肟。结果:治疗组痊愈26例,显效7例,有效3例,无效0例,总显效率为91.7%;对照组痊愈16例,显效11例,有效7例,无效2例,总显效率为75.0%;两组总显效率比较差异有统计学意义。治疗组体温及白细胞计数恢复正常时间,咳嗽、喘息、呼吸困难消失和肺部啰音消失时间均显著短于对照组,差异有统计学意义。结论:痰热清注射液具有良好的退热、抗病毒、抗炎症作用,治疗小儿重症肺炎安全、有效。
Objective: To observe the clinical effect of Tanreqing Injection in treating pediatric severe pneumonia. Methods: Seventy-two children with severe pneumonia were randomly divided into treatment group and control group, with 36 cases in each. The two groups were given the same routine treatment. The treatment group was given Tanreqing + Cefmenoxime on the basis of routine treatment, while the control group Give ribavirin + cefmenoxime. Results: The treatment group cured 26 cases, 7 cases markedly effective, 3 cases effective, 0 cases ineffective, the total effective rate was 91.7%; control group cured 16 cases, markedly effective in 11 cases, effective in 7 cases, ineffective in 2 cases, the total effective rate was 75.0 %; Total effective rate was significantly different between the two groups. The treatment group, body temperature and white blood cell count returned to normal time, cough, wheezing, dyspnea disappeared and pulmonary rales disappeared significantly shorter than the control group, the difference was statistically significant. Conclusion: Tanreqing injection has a good antipyretic, anti-viral, anti-inflammatory effect, the treatment of severe pneumonia in children safe and effective.